EDAP Installs First Ablatherm-HIFU Device In Mexico

Lyon, France - EDAP TMS SA, the global leader in therapeutic ultrasound, announced recently the first installation of its Ablatherm-HIFU (high intensity focused ultrasound) machine at Centro Medico Puerta de Hierro Hospital in Guadalajara, Mexico. The clinic adopted the Ablatherm robotic HIFU system through a revenue per procedure (RPP) contract.

Dr. Jorge Gutierrez Aceves, MD, Head of the Prostate Institute at Centro Medico Puerta de Hierro Hospital, stated, "We are excited to be the first hospital in Mexico to launch and successfully perform Ablatherm-HIFU procedures. Our hospital strives to be at the forefront of novel cancer treatment approaches with the potential to provide greater efficacy, fewer side effects, and better quality of life for patients and their families. We see great promise for Ablatherm-HIFU as a targeted, minimally invasive treatment for localized prostate cancer and look forward to offering this treatment to more patients in the weeks to come."

Marc Oczachowski, EDAP's Chief Executive Officer, commented, "The global expansion of Ablatherm-HIFU into key geographic markets has continued to drive adoption and positively impact EDAP's business. Our entrance into Mexico highlights EDAP's growth potential in the third largest market in the Americas. We look forward to working with Dr. Gutierrez, a pioneer in introducing new innovative urological techniques in Mexico. We believe our close and successful cooperation will provide quicker, easier and expanded access to Ablatherm-HIFU."

Marc Oczachowski continued, "We are pleased to also announce the approval of our Ablatherm device in Brazil, opening new opportunities for EDAP's business in Latin American. We are currently working closely with our distributor in Brazil to target clinical sites and offer the technology to those patients with prostate cancer in Brazil".

SOURCE: EDAP TMS S.A.